Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open Label, Multicentre, Randomised Controlled Trial Comparing Hyperthermia Plus Mitomycin To Mitomycin Alone In Patients With Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06768346 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT06768346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06768346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open Label, Multicentre, Randomised Controlled Trial Comparing Hyperthermia Plus Mitomycin To Mitomycin Alone In Patients With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2014
Completion date
May 27, 2020
Enrollment
259 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer